Skip to main content

Hematologic and Lymphoid Neoplasia

  • Chapter
  • First Online:
Serous Effusions

Abstract

Serous effusions are commonly seen in lymphomas, in about 20–30% of cases, and are less frequently seen with myeloid malignancy.1,2 In children, effusions are more commonly associated with lymphoma and leukemia than with other malignancies.3 Most effusions are secondary, and are caused by direct infiltration with leukemia or lymphoma from an adjacent disease location, by obstruction of the lymphatic system draining the body cavity by lymphoma or by infection secondary to immune depression due to extensive marrow involvement or secondary to the treatment of lymphoma or leukemia. In addition, effusions may also be caused by inflammation following direct damage by radiation, chemotherapy, and novel tyrosine-kinase inhibitors such as dasatinib or by graft versus host disease in the case of bone marrow transplantation for the malignancy.46 In this section, only serous effusions arising from direct lymphoma or leukemia infiltration of a body cavity will be discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Alexandrakis MG, Passam FH, Kyriakou DS, Bouros D. Pleural effusions in hematologic malignancies. Chest. 2004;125:1546-1555.

    Article  PubMed  Google Scholar 

  2. Das DK. Serous effusions in malignant lymphomas: a review. Diagn Cytopathol. 2006;34:335-347.

    Article  PubMed  Google Scholar 

  3. Wong JW, Pitlik D, Abdul-Karim FW. Cytology of pleural, peritoneal and pericardial fluids in children. A 40-year summary. Acta Cytol. 1997;41:467-473.

    Article  PubMed  CAS  Google Scholar 

  4. Van Renterghem DM, Pauwels RA. Chylothorax and pleural effusion as late complications of thoracic irradiation. Chest. 1995;108:886-887.

    Article  PubMed  Google Scholar 

  5. Brixey AG, Light RW. Pleural effusions due to dasatinib. Curr Opin Pulm Med. 2010;16:351-356.

    Article  PubMed  Google Scholar 

  6. Seber A, Khan SP, Kersey JH. Unexplained effusions: association with allogeneic bone marrow transplantation and acute or chronic graft-versus-host disease. Bone Marrow Transplant. 1996;17:207-211.

    PubMed  CAS  Google Scholar 

  7. Swerdlow SH, Campo E, Harris NL, et al., eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC; 2008.

    Google Scholar 

  8. Thompson PA, Lade S, Webster H, Ryan G, Prince HM. Effusion-associated anaplastic large cell lymphoma of the breast: time for it to be defined as a distinct clinico-pathological entity. Haematologica. 2010;95:1977-1979.

    Article  PubMed  Google Scholar 

  9. Mitchell A, Meunier C, Ouellette D, Colby T. Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue with initial presentation in the pleura. Chest. 2006;129:791-794.

    Article  PubMed  Google Scholar 

  10. Motta G, Conticello C, Amato G, et al. Pleuric presentation of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue: a case report and a review of the literature. Int J Hematol. 2010;92:369-373.

    Article  PubMed  Google Scholar 

  11. Pullarkat VA, Medeiros LJ, Brynes RK. Body cavity-based presentation of natural killer cell lymphoma. Leuk Lymphoma. 2005;46:293-296.

    Article  PubMed  Google Scholar 

  12. Chaves FP, Quillen K, Xu D. Pericardial effusion: a rare presentation of adult T-cell leukemia/lymphoma. Am J Hematol. 2004;77:381-383.

    Article  PubMed  Google Scholar 

  13. Czader M, Ali SZ. Flow cytometry as an adjunct to cytomorphologic analysis of serous effusions. Diagn Cytopathol. 2003;29:74-78.

    Article  PubMed  Google Scholar 

  14. Bangerter M, Brudler O, Heinrich B, Griesshamnuer M. Fine needle aspiration cytology and flow cytometry in the diagnosis and subclassification of non-Hodgkin’s lymphoma based on the World Health Organization classification. Acta Cytol. 2007;51:390-398.

    Article  PubMed  Google Scholar 

  15. Evans PA, Pott Ch, Groenen PJ, et al. Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia. 2007;21:207-214.

    Article  PubMed  CAS  Google Scholar 

  16. Brüggemann M, White H, Gaulard P, et al. Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies. Report of the BIOMED-2 Concerted Action BHM4 CT98-3936. Leukemia. 2007;21:215-221.

    Article  PubMed  Google Scholar 

  17. Langerak AW, Molina TJ, Lavender FL, et al. Polymerase chain reaction-based clonality testing in tissue samples with reactive lymphoproliferations: usefulness and pitfalls. A report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2007;21:222-229.

    Article  PubMed  CAS  Google Scholar 

  18. Mann G, Attarbaschi A, Steiner M, et al. Austrian Berlin-Frankfurt-Münster (BFM) Group. Early and reliable diagnosis of non-Hodgkin lymphoma in childhood and adolescence: contribution of cytomorphology and flow cytometric immunophenotyping. Pediatr Hematol Oncol. 2006;2:167-176.

    Article  Google Scholar 

  19. Mathiot C, Decaudin D, Klijanienko J, et al. Fine-needle aspiration cytology combined with flow cytometry immunophenotyping is a rapid and accurate approach for the evaluation of suspicious superficial lymphoid lesions. Diagn Cytopathol. 2006;34:472-478.

    Article  PubMed  Google Scholar 

  20. Mathur S, Dawar R, Verma K. Diagnosis and grading of non-Hodgkin’s lymphomas on fine needle aspiration cytology. Indian J Pathol Microbiol. 2007;50:46-50.

    PubMed  Google Scholar 

  21. Nador RG, Cesarman E, Chadburn A, et al. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi’s sarcoma-associated herpes virus. Blood. 1996;88:645-656.

    PubMed  CAS  Google Scholar 

  22. Carbone A, Gloghini A. HHV-8-associated lymphoma: state-of-the-art review. Acta Haematol. 2007;117:129-131.

    Article  PubMed  Google Scholar 

  23. Jones D, Ballestas ME, Kaye KM, et al. Primary-effusion lymphoma and Kaposi’s sarcoma in a cardiac-transplant recipient. N Engl J Med. 1998;339:444-449.

    Article  PubMed  CAS  Google Scholar 

  24. Dotti G, Fiocchi R, Motta T, et al. Primary effusion lymphoma after heart transplantation: a new entity associated with human herpesvirus-8. Leukemia. 1999;13:664-670.

    Article  PubMed  CAS  Google Scholar 

  25. Ichinohasama R, Miura I, Kobayashi N, et al. Herpes virus type 8-negative primary effusion lymphoma associated with PAX-5 gene rearrangement and hepatitis C virus: a case report and review of the literature. Am J Surg Pathol. 1998;22:1528-1537.

    Article  PubMed  CAS  Google Scholar 

  26. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science. 1994;266:1865-1869.

    Article  PubMed  CAS  Google Scholar 

  27. Du MQ, Bacon CM, Isaacson PG. Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 and lymphoproliferative disorders. J Clin Pathol. 2007;60:1350-1357.

    Article  PubMed  Google Scholar 

  28. Polskj JM, Evans HL, Grosso LE, Popovic WJ, Taylor L, Dunphy CH. CD7 and CD56-positive primary effusion lymphoma in a human immunodeficiency virus-negative host. Leuk Lymphoma. 2000;39:633-639.

    Article  PubMed  CAS  Google Scholar 

  29. Chen YB, Rahemtullah A, Hochberg E. Primary effusion lymphoma. Oncologist. 2007;12:569-576.

    Article  PubMed  Google Scholar 

  30. Iuchi K, Ichimiya A, Akashi A, et al. Non-Hodgkin’s lymphoma of the pleural cavity developing from long-standing pyothorax. Cancer. 1987;60:1771-1775.

    Article  PubMed  CAS  Google Scholar 

  31. Aozasa K. Pyothorax-associated lymphoma. J Clin Exp Hematop. 2006;46:5-10.

    Article  PubMed  Google Scholar 

  32. Nakatsuka S, Yao M, Hoshida Y, Yamamoto S, Iuchi K, Aozasa K. Pyothorax-associated lymphoma: a review of 106 cases. J Clin Oncol. 2002;20:4255-4260.

    Article  PubMed  Google Scholar 

  33. Kuriyama Y, Nakajima A, Shimizu N, Ohyashiki JH, Mukai K, Ohyashiki K. Detection of Epstein-Barr virus in a pyothorax-associated lymphoma with T-cell phenotype. Haematologica. 2002;87:ECR28.

    PubMed  Google Scholar 

  34. Hongyo T, Kurooka M, Taniguchi E, et al. Frequent p53 mutations at dipyrimidine sites in patients with pyothorax-associated lymphoma. Cancer Res. 1998;58:1105-1107.

    PubMed  CAS  Google Scholar 

  35. Gaudet G, Friedberg JW, Weng A, Pinkus GS, Freedman AS. Breast lymphoma associated with breast implants: two case-reports and a review of the literature. Leuk Lymphoma. 2002;43:115-119.

    Article  PubMed  Google Scholar 

  36. Lipworth L, Tarone RE, McLaughlin JK. Breast implants and lymphoma risk: a review of the epidemiologic evidence through 2008. Plast Reconstr Surg. 2009;123:790-793.

    Article  PubMed  CAS  Google Scholar 

  37. de Jong D, Vasmel WL, de Boer JP, et al. Anaplastic large-cell lymphoma in women with breast implants. JAMA. 2008;300:2030-2035.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anne M. Tierens M.D., Ph.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag London Limited

About this chapter

Cite this chapter

Tierens, A.M. (2012). Hematologic and Lymphoid Neoplasia. In: Davidson, B., Firat, P., Michael, C. (eds) Serous Effusions. Springer, London. https://doi.org/10.1007/978-0-85729-697-9_6

Download citation

  • DOI: https://doi.org/10.1007/978-0-85729-697-9_6

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-0-85729-696-2

  • Online ISBN: 978-0-85729-697-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics